一种ZIF-8 / Hb混合LB薄膜的制备工艺

By preparing ZIF-8/Hb nanoparticles and ultrasonically dispersing them in an isooctane solution of sodium dioctyl succinate sulfonate, combined with π-A curves and a multifunctional LB film stretching machine, the problem of ZIF-8/Hb nanoparticles forming films at the gas-liquid interface was solved, achieving a highly stable and highly sensitive biosensing interface. This enabled the controllable preparation and performance customization of ZIF-8/Hb hybrid LB films.

CN121045601BActive Publication Date: 2026-07-17JILIN INST OF CHEM TECH

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
JILIN INST OF CHEM TECH
Filing Date
2025-08-28
Publication Date
2026-07-17

AI Technical Summary

Technical Problem

ZIF-8/Hb nanoparticles tend to aggregate and settle in aqueous phases, making it difficult to form a uniform monolayer at the gas-liquid interface. LB films constructed using traditional physical mixing methods suffer from pore collapse and Hb leakage. Pure Hb is difficult to form a film independently, and ZIF-8 molecules are loosely arranged and collapse under pressure, making it difficult to support multiple rounds of film stretching operations.

Method used

By preparing ZIF-8/Hb nanoparticles and ultrasonically dispersing them in an isooctane solution of sodium dioctyl succinate sulfonate, combined with π-A curves and a multifunctional LB film stretching machine, and setting intelligent film stretching parameters, the preparation of ZIF-8/Hb mixed LB films was achieved, thus solving the bottleneck of nanoparticle film formation and the retention of bioactivity.

Benefits of technology

The interfacial stability of ZIF-8/Hb nanoparticles was achieved, the bioelectrochemical activity of Hb was preserved, a highly sensitive biosensing interface was provided, and the film performance was customized through intelligent process parameter control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121045601B_ABST
    Figure CN121045601B_ABST
Patent Text Reader

Abstract

本发明涉及复合薄膜技术领域,具体涉及一种ZIF‑8 / Hb混合LB薄膜的制备工艺,包括以下步骤:将血红蛋白溶液加入到六水合硝酸锌的水溶液中,搅拌反应,得到第一反应溶液;将2‑甲基咪唑的水溶液加入到第一反应溶液,搅拌反应,离心洗涤后干燥,得到ZIF‑8 / Hb纳米颗粒;将ZIF‑8 / Hb纳米颗粒加入丁二酸二辛酯磺酸钠的异辛烷溶液中,超声分散,得到第二反应溶液;绘制出ZIF‑8 / Hb的π‑A曲线,通过多功能LB膜拉膜机并设定拉膜参数,制备得到ZIF‑8 / Hb膜;本发明实现反胶束协同稳定界面,突破纳米颗粒成膜瓶颈、生物活性精准保留,赋能电化学传感界面和工艺参数智能化调控,实现薄膜性能可定制化的效果。
Need to check novelty before this filing date? Find Prior Art